1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Crump, M.P. Elisseeva, E. Gong, J.-H. Clark-Lewis, I. Sykes, B.D. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking NE FEBS Lett. FEBLAL 0165 0014-5793 489 171 10.1016/S0014-5793(00)02393-0 11165244 Structure/Function of Human Herpesvirus-8 Mip-II (1-71) and the Antagonist N-Terminal Segment (1-10) 2001 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 8142.661 VIRAL MACROPHAGE INFLAMMATORY PROTEIN-II RESIDUES 1-71 1 syn polymer VMIP-II, VMIP-1B no no LGASWHRPDKCCLGYQKRPLPQVLLSSWYPTSQLCSKPGVIFLTKRGRQVCADKSKDWVKKLMQQLPVTAR LGASWHRPDKCCLGYQKRPLPQVLLSSWYPTSQLCSKPGVIFLTKRGRQVCADKSKDWVKKLMQQLPVTAR A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n repository Initial release Version format compliance Version format compliance 1 0 2001-01-07 1 1 2011-05-08 1 2 2011-07-13 NMR SOLUTION STRUCTURES OF THE VMIP-II 1-71 PEPTIDE FROM KAPOSI'S SARCOMA-ASSOCIATED HERPESVIRUS. NMR, MINIMISED AVERAGE STRUCTURE NMR SOLUTION STRUCTURES OF THE VMIP-II 1-10 PEPTIDE FROM KAPOSI'S SARCOMA-ASSOCIATED HERPESVIRUS. (RESIDUES 1-10 55 STRUCTURES) CRYSTAL STRUCTURE OF VIRAL MACROPHAGE INFLAMMATORY PROTEIN-II STRUCTURE OF THE ANTI-HIV CHEMOKINE VMIP-II PDBE Y PDBE 2000-12-07 REL 37296 HUMAN HERPESVIRUS 8 sample SEE 1HFG FOR MINIMIZED AVERAGE STRUCTURE. SEE PAPER FOR FURTHER EXPERIMENTAL DETAILS. LEAST RESTRAINT VIOLATION 38 38 DQF-COSY TOCSY NOESY 5.0 pH 1 atm 303 K REFINEMENT DETAILS CAN BE FOUND IN THE JOURNAL CITATION. simulated annealing 1MM DSS, 1MM NAN3, 20MM SODIUM ACETATE BRUNGER refinement X-PLOR structure solution X-PLOR 600 Varian UNITY LEU 1 n 1 LEU 1 A GLY 2 n 2 GLY 2 A ALA 3 n 3 ALA 3 A SER 4 n 4 SER 4 A TRP 5 n 5 TRP 5 A HIS 6 n 6 HIS 6 A ARG 7 n 7 ARG 7 A PRO 8 n 8 PRO 8 A ASP 9 n 9 ASP 9 A LYS 10 n 10 LYS 10 A CYS 11 n 11 CYS 11 A CYS 12 n 12 CYS 12 A LEU 13 n 13 LEU 13 A GLY 14 n 14 GLY 14 A TYR 15 n 15 TYR 15 A GLN 16 n 16 GLN 16 A LYS 17 n 17 LYS 17 A ARG 18 n 18 ARG 18 A PRO 19 n 19 PRO 19 A LEU 20 n 20 LEU 20 A PRO 21 n 21 PRO 21 A GLN 22 n 22 GLN 22 A VAL 23 n 23 VAL 23 A LEU 24 n 24 LEU 24 A LEU 25 n 25 LEU 25 A SER 26 n 26 SER 26 A SER 27 n 27 SER 27 A TRP 28 n 28 TRP 28 A TYR 29 n 29 TYR 29 A PRO 30 n 30 PRO 30 A THR 31 n 31 THR 31 A SER 32 n 32 SER 32 A GLN 33 n 33 GLN 33 A LEU 34 n 34 LEU 34 A CYS 35 n 35 CYS 35 A SER 36 n 36 SER 36 A LYS 37 n 37 LYS 37 A PRO 38 n 38 PRO 38 A GLY 39 n 39 GLY 39 A VAL 40 n 40 VAL 40 A ILE 41 n 41 ILE 41 A PHE 42 n 42 PHE 42 A LEU 43 n 43 LEU 43 A THR 44 n 44 THR 44 A LYS 45 n 45 LYS 45 A ARG 46 n 46 ARG 46 A GLY 47 n 47 GLY 47 A ARG 48 n 48 ARG 48 A GLN 49 n 49 GLN 49 A VAL 50 n 50 VAL 50 A CYS 51 n 51 CYS 51 A ALA 52 n 52 ALA 52 A ASP 53 n 53 ASP 53 A LYS 54 n 54 LYS 54 A SER 55 n 55 SER 55 A LYS 56 n 56 LYS 56 A ASP 57 n 57 ASP 57 A TRP 58 n 58 TRP 58 A VAL 59 n 59 VAL 59 A LYS 60 n 60 LYS 60 A LYS 61 n 61 LYS 61 A LEU 62 n 62 LEU 62 A MET 63 n 63 MET 63 A GLN 64 n 64 GLN 64 A GLN 65 n 65 GLN 65 A LEU 66 n 66 LEU 66 A PRO 67 n 67 PRO 67 A VAL 68 n 68 VAL 68 A THR 69 n 69 THR 69 A ALA 70 n 70 ALA 70 A ARG 71 n 71 ARG 71 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O SER 27 A O SER 27 A N LEU 43 A N LEU 43 A O VAL 40 A O VAL 40 A N ALA 52 A N ALA 52 13 A A O H LEU LEU 62 66 1.60 22 A A HZ1 OE1 LYS GLN 10 49 1.58 1 A ALA 3 -96.73 -70.15 1 A SER 4 -176.52 92.65 1 A HIS 6 61.01 110.18 1 A ARG 7 -174.66 82.69 1 A ASP 9 69.46 -67.85 1 A LYS 10 -178.63 -75.56 1 A CYS 11 58.68 107.34 1 A SER 26 -129.90 -64.10 1 A LYS 56 -60.16 -175.20 1 A PRO 67 -78.84 -78.56 1 A VAL 68 172.13 163.85 2 A ALA 3 -172.51 -68.82 2 A SER 4 -140.84 -70.63 2 A TRP 5 -172.60 123.02 2 A HIS 6 -153.26 -70.71 2 A ASP 9 -176.70 48.61 2 A LYS 10 -99.55 31.77 2 A SER 26 -133.32 -68.33 2 A LYS 56 -60.41 -174.32 2 A PRO 67 -79.47 -79.56 2 A VAL 68 168.98 156.39 2 A ALA 70 60.79 109.78 3 A ARG 7 -163.16 85.93 3 A LYS 10 -161.16 32.12 3 A CYS 11 -61.88 -173.02 3 A CYS 12 -102.63 79.77 3 A LYS 37 -162.06 78.53 3 A LYS 56 -61.77 -175.88 3 A PRO 67 -78.18 -78.93 3 A VAL 68 177.63 163.34 4 A ASP 9 -165.71 81.64 4 A LYS 10 -176.67 38.25 4 A CYS 11 -61.74 -174.67 4 A SER 26 -130.97 -58.25 4 A LYS 56 -59.84 -174.30 4 A ASP 57 -97.02 -64.83 4 A PRO 67 -78.39 -84.85 4 A VAL 68 176.56 140.32 5 A ALA 3 60.66 93.06 5 A HIS 6 -164.77 -44.91 5 A ARG 7 -151.29 87.48 5 A ASP 9 -68.13 83.43 5 A LYS 10 -177.66 -64.96 5 A CYS 11 -101.48 74.06 5 A LYS 17 88.17 -41.52 5 A SER 36 58.31 19.19 5 A LYS 37 -170.32 64.60 5 A LYS 56 -61.00 -174.22 5 A PRO 67 -76.71 -83.02 5 A VAL 68 177.49 166.04 6 A ALA 3 60.68 88.57 6 A SER 4 60.67 178.19 6 A ARG 7 60.42 88.06 6 A LYS 10 -178.59 -40.42 6 A CYS 12 -178.75 120.66 6 A SER 36 69.61 -66.85 6 A LYS 56 -67.40 -172.73 6 A PRO 67 -76.93 -82.85 6 A VAL 68 177.12 164.55 6 A ALA 70 60.77 166.02 7 A TRP 5 -146.12 40.05 7 A CYS 11 59.11 107.99 7 A SER 26 -123.13 -63.66 7 A LYS 37 -159.99 71.85 7 A LYS 56 -60.93 -177.32 7 A ASP 57 -99.37 -60.37 7 A PRO 67 -76.77 -82.19 7 A VAL 68 178.67 167.63 7 A ALA 70 60.57 94.11 8 A SER 4 55.22 -177.39 8 A TRP 5 -171.82 143.10 8 A ASP 9 -177.72 -40.63 8 A CYS 12 66.16 113.09 8 A LYS 17 88.40 -43.79 8 A SER 26 -130.32 -68.34 8 A SER 32 -62.29 -99.40 8 A GLN 33 177.30 -40.77 8 A LEU 34 -97.22 38.65 8 A CYS 35 -98.61 33.02 8 A SER 36 69.69 -65.52 8 A LYS 56 -60.28 -178.13 8 A PRO 67 -77.78 -78.64 8 A VAL 68 177.65 163.15 8 A ALA 70 -170.43 -52.01 9 A SER 4 60.63 168.33 9 A TRP 5 62.43 115.22 9 A HIS 6 -66.18 84.95 9 A CYS 12 65.50 -73.38 9 A SER 26 -133.12 -58.02 9 A SER 36 68.82 -68.91 9 A LYS 56 -60.61 -176.82 9 A PRO 67 -77.61 -81.96 9 A THR 69 -58.48 176.60 10 A ALA 3 60.78 109.75 10 A LYS 10 -168.42 34.30 10 A CYS 11 -62.08 -174.26 10 A ARG 18 -170.56 147.51 10 A SER 26 -106.79 -66.45 10 A CYS 35 -106.95 -73.02 10 A SER 36 -174.84 -41.80 10 A LYS 37 -166.84 63.71 10 A LYS 56 -60.33 -174.06 10 A PRO 67 -77.06 -82.85 10 A VAL 68 177.52 153.87 10 A ALA 70 -173.09 -65.48 11 A ALA 3 -177.29 99.92 11 A SER 4 60.60 106.14 11 A ARG 7 174.98 -54.83 11 A LYS 17 86.81 -45.19 11 A SER 26 -131.47 -67.52 11 A CYS 35 -61.52 -170.97 11 A LYS 37 -170.65 63.81 11 A LYS 56 -58.57 177.37 11 A PRO 67 -79.23 -79.01 11 A VAL 68 169.73 154.26 11 A THR 69 -61.45 89.14 11 A ALA 70 -64.02 84.82 12 A ALA 3 69.01 -68.36 12 A SER 4 55.64 171.34 12 A TRP 5 -164.93 32.70 12 A ASP 9 60.79 96.54 12 A CYS 12 61.98 115.55 12 A SER 26 -128.57 -74.85 12 A LEU 34 -152.04 48.61 12 A CYS 35 -115.27 -72.34 12 A SER 36 -179.81 -43.38 12 A LYS 37 -170.08 62.83 12 A LYS 56 -59.90 -176.65 12 A PRO 67 -78.64 -78.64 12 A VAL 68 172.61 163.11 12 A ALA 70 -175.43 95.60 13 A SER 4 -80.70 -70.73 13 A HIS 6 -177.50 82.13 13 A ARG 7 60.81 158.93 13 A LYS 17 86.10 -43.82 13 A SER 26 -126.61 -67.06 13 A CYS 35 -103.27 -73.36 13 A SER 36 178.84 -39.67 13 A LYS 37 -162.08 64.28 13 A LYS 56 -60.77 -178.09 13 A PRO 67 -78.73 -86.18 13 A VAL 68 172.21 131.82 14 A ARG 7 60.45 85.45 14 A ASP 9 60.60 109.16 14 A LYS 10 -176.43 -66.58 14 A CYS 11 -63.09 -179.35 14 A CYS 12 178.84 116.88 14 A SER 26 -126.38 -66.85 14 A LYS 56 -62.31 -175.92 14 A PRO 67 -77.83 -85.91 14 A VAL 68 176.19 146.15 14 A ALA 70 61.08 157.36 15 A ALA 3 -146.78 32.64 15 A HIS 6 -107.51 -64.92 15 A LYS 10 -175.09 93.00 15 A SER 26 -124.12 -69.52 15 A LYS 56 -58.39 -176.71 15 A PRO 67 -75.19 -82.97 15 A VAL 68 179.41 172.64 15 A ALA 70 -62.21 -70.95 16 A ALA 3 -172.96 127.06 16 A SER 4 60.72 170.67 16 A CYS 11 -55.16 -173.76 16 A LEU 13 70.42 -66.43 16 A ARG 18 -173.43 146.24 16 A LYS 56 -59.39 -173.29 16 A PRO 67 -78.55 -78.77 16 A VAL 68 171.69 163.39 17 A TRP 5 69.79 -66.58 17 A HIS 6 -62.37 -70.77 17 A LYS 10 -155.80 -46.11 17 A CYS 12 58.94 106.23 17 A LYS 17 85.75 -45.11 17 A SER 26 -131.39 -73.57 17 A CYS 35 -59.83 -174.57 17 A LYS 56 -59.19 -178.04 17 A PRO 67 -76.72 -85.48 17 A VAL 68 178.19 161.70 17 A ALA 70 60.60 97.45 18 A SER 4 -99.66 -61.50 18 A TRP 5 60.88 157.65 18 A LYS 10 66.88 -71.16 18 A CYS 11 -61.23 -173.21 18 A SER 26 -109.50 -67.49 18 A SER 36 69.86 -61.69 18 A CYS 51 -69.61 97.18 18 A LYS 56 -65.15 -177.97 18 A PRO 67 -76.90 -83.03 18 A VAL 68 178.48 172.05 18 A ALA 70 -166.15 33.34 19 A TRP 5 60.72 167.56 19 A HIS 6 60.38 84.57 19 A LYS 10 -70.96 -166.53 19 A LYS 56 -60.22 -173.05 19 A PRO 67 -77.47 -81.27 19 A VAL 68 164.04 156.55 19 A ALA 70 60.62 166.43 20 A SER 4 69.30 -62.30 20 A TRP 5 -68.11 82.40 20 A HIS 6 -177.81 122.17 20 A ARG 7 174.89 -53.45 20 A ASP 9 -75.75 -70.99 20 A LYS 10 -150.45 30.69 20 A CYS 11 -61.82 -172.27 20 A SER 26 -98.42 -66.40 20 A LYS 56 -61.50 -174.63 20 A ASP 57 -100.18 -62.33 20 A VAL 68 120.62 156.66 20 A ALA 70 65.41 -77.26 21 A SER 4 60.63 93.00 21 A HIS 6 -177.65 102.80 21 A ARG 7 60.41 165.53 21 A LYS 10 69.71 -65.67 21 A CYS 12 61.59 113.21 21 A SER 26 -122.83 -66.64 21 A LYS 37 -170.03 73.52 21 A LYS 56 -68.10 -175.83 21 A PRO 67 -76.63 -84.62 21 A VAL 68 179.79 170.26 21 A ALA 70 -178.09 -70.64 22 A HIS 6 60.81 102.08 22 A CYS 11 -61.67 -174.39 22 A SER 26 -124.44 -54.84 22 A SER 27 -174.03 -167.56 22 A SER 32 -57.96 177.24 22 A LEU 34 -72.79 -83.41 22 A SER 36 69.14 -68.74 22 A PRO 38 -76.30 -166.51 22 A ALA 52 -170.03 135.60 22 A LYS 56 -57.80 -177.27 22 A ASP 57 -96.57 -65.34 22 A VAL 68 113.52 152.57 22 A ALA 70 -160.36 105.22 23 A ASP 9 -68.12 -76.48 23 A LYS 10 -179.00 38.19 23 A CYS 12 60.99 78.48 23 A LYS 17 87.21 -41.96 23 A SER 26 -133.94 -71.53 23 A LYS 56 -60.79 -173.83 23 A PRO 67 -77.16 -83.84 23 A VAL 68 177.18 139.44 24 A SER 4 -169.24 96.27 24 A TRP 5 60.83 107.86 24 A HIS 6 -178.75 107.84 24 A ARG 7 -171.65 88.51 24 A CYS 11 -59.59 -174.06 24 A CYS 12 -178.75 90.68 24 A SER 26 -127.62 -67.36 24 A SER 36 69.93 -62.08 24 A LYS 56 -62.09 -175.86 24 A PRO 67 -78.35 -79.15 24 A VAL 68 176.10 161.49 24 A ALA 70 -160.17 32.91 25 A ALA 3 -174.36 114.98 25 A SER 4 -163.09 32.89 25 A LYS 10 -167.49 33.93 25 A CYS 11 -62.55 -172.92 25 A ARG 18 -173.47 147.80 25 A SER 26 -129.32 -67.40 25 A GLN 33 -99.23 41.99 25 A LEU 34 -151.72 48.03 25 A SER 36 70.96 -65.10 25 A LYS 37 -118.73 79.95 25 A LYS 56 -58.95 -173.89 25 A PRO 67 -76.67 -85.12 25 A VAL 68 177.11 139.14 25 A ALA 70 -69.50 -172.53 26 A SER 4 -177.36 117.21 26 A ARG 7 60.48 88.77 26 A ASP 9 60.45 83.54 26 A SER 26 -135.69 -66.13 26 A LYS 56 -58.28 -174.05 26 A ASP 57 -95.55 -64.49 26 A PRO 67 -75.76 -88.23 26 A VAL 68 179.48 161.61 26 A ALA 70 -69.61 -70.60 27 A SER 4 60.57 84.15 27 A TRP 5 -170.53 89.28 27 A ASP 9 -150.64 83.97 27 A LYS 10 -154.63 32.43 27 A CYS 12 64.39 138.91 27 A SER 26 -108.95 -66.85 27 A SER 32 -86.27 -89.66 27 A GLN 33 177.13 -37.99 27 A LYS 56 -60.45 -175.75 27 A PRO 67 -77.66 -81.95 27 A VAL 68 164.64 156.33 27 A THR 69 -60.79 99.58 28 A SER 4 55.25 176.09 28 A ASP 9 60.69 104.75 28 A CYS 12 60.90 101.77 28 A SER 26 -121.54 -64.08 28 A LYS 37 -152.99 88.39 28 A LYS 56 -58.55 -177.54 28 A PRO 67 -76.05 -82.77 28 A VAL 68 177.82 170.96 29 A ALA 3 -176.85 123.00 29 A ASP 9 60.93 110.80 29 A CYS 12 37.28 97.17 29 A SER 26 -123.64 -66.95 29 A CYS 35 -118.50 -74.72 29 A SER 36 -179.31 -46.34 29 A LYS 37 -167.63 63.87 29 A LYS 56 -64.39 -172.51 29 A PRO 67 -79.00 -78.55 29 A VAL 68 178.76 163.41 30 A TRP 5 -177.73 -40.66 30 A ARG 7 60.49 89.32 30 A CYS 11 57.40 -174.29 30 A CYS 12 -170.35 112.81 30 A LYS 17 85.84 -44.11 30 A SER 27 -177.30 -171.81 30 A THR 31 -69.48 -176.22 30 A SER 32 -77.69 -89.53 30 A GLN 33 177.11 -37.49 30 A PRO 67 -77.75 -86.96 30 A VAL 68 176.32 152.00 30 A ALA 70 -157.51 -70.65 31 A ARG 7 60.40 86.41 31 A ASP 9 -78.32 -70.76 31 A LYS 10 -177.52 88.76 31 A CYS 12 60.11 159.62 31 A SER 26 -102.74 -67.18 31 A LYS 37 -151.64 75.85 31 A LYS 56 -63.56 -172.46 31 A PRO 67 -78.83 -78.27 31 A VAL 68 172.46 163.64 32 A ALA 3 -148.21 -49.15 32 A ASP 9 60.66 85.62 32 A CYS 12 61.08 110.24 32 A LYS 17 88.07 -42.22 32 A SER 26 -131.08 -67.40 32 A PRO 67 -74.25 -89.17 32 A ALA 70 60.64 159.22 33 A TRP 5 -142.69 32.91 33 A HIS 6 -102.82 -70.66 33 A SER 26 -109.90 -67.01 33 A GLN 33 -103.00 40.86 33 A LEU 34 -152.37 41.14 33 A SER 36 71.34 -63.23 33 A LYS 56 -60.20 -173.40 33 A ASP 57 -99.10 -62.04 33 A PRO 67 -79.36 -78.73 33 A VAL 68 170.04 144.38 34 A TRP 5 -132.99 -73.87 34 A ARG 7 60.26 87.99 34 A CYS 12 65.89 119.22 34 A GLN 33 -99.59 30.49 34 A CYS 35 -60.13 -172.85 34 A LYS 56 -56.82 -176.19 34 A PRO 67 -77.14 -85.22 34 A VAL 68 178.18 141.65 34 A THR 69 41.07 95.13 35 A TRP 5 -150.89 -67.84 35 A HIS 6 -178.75 120.88 35 A ARG 7 60.36 81.19 35 A LYS 10 -177.64 95.85 35 A CYS 12 61.26 84.99 35 A LYS 17 86.69 -41.98 35 A GLN 33 -93.86 48.24 35 A LEU 34 -150.40 32.74 35 A LYS 56 -59.88 -173.16 35 A ASP 57 -99.64 -61.94 35 A PRO 67 -75.99 -82.51 35 A VAL 68 179.77 172.43 35 A ALA 70 60.68 162.61 36 A ALA 3 -164.55 -46.16 36 A SER 4 -172.01 103.30 36 A HIS 6 -140.57 -47.96 36 A ASP 9 -177.57 85.82 36 A CYS 11 -61.53 -178.05 36 A LYS 17 87.35 -42.94 36 A GLN 33 -94.96 45.75 36 A LEU 34 -150.55 47.30 36 A LYS 37 -170.00 79.43 36 A ALA 52 -170.19 126.77 36 A ASP 53 -65.27 -175.56 36 A LYS 56 -57.88 -178.21 36 A PRO 67 -78.02 -84.36 36 A VAL 68 174.83 135.58 36 A ALA 70 -161.01 32.73 37 A SER 4 60.56 167.61 37 A CYS 11 58.14 165.74 37 A LYS 17 87.03 -43.40 37 A PRO 38 -79.26 -166.90 37 A LYS 56 -57.38 -174.24 37 A ASP 57 -102.32 -60.12 37 A PRO 67 -77.07 -78.11 37 A VAL 68 175.60 143.92 37 A ALA 70 -169.86 -59.43 38 A ALA 3 -135.79 -53.15 38 A SER 4 -176.56 -70.96 38 A ARG 7 60.47 64.72 38 A LYS 10 -98.91 -72.23 38 A CYS 11 -61.99 -175.50 38 A CYS 12 177.83 126.09 38 A LYS 17 87.60 -42.60 38 A SER 26 -126.14 -66.54 38 A LYS 56 -59.79 -174.23 38 A ASP 57 -101.35 -60.12 38 A PRO 67 -78.64 -78.78 38 A VAL 68 171.63 160.40 38 A ALA 70 60.61 87.66 VIRAL MACROPHAGE INFLAMMATORY PROTEIN-II NMR solution structures of vMIP-II 1-71 from Kaposi's sarcoma-associated herpesvirus. 1 N N A ASP 57 A ASP 57 HELX_P A LEU 66 A LEU 66 1 1 10 disulf 2.018 A CYS 11 A SG CYS 11 1_555 A CYS 35 A SG CYS 35 1_555 disulf 2.019 A CYS 12 A SG CYS 12 1_555 A CYS 51 A SG CYS 51 1_555 CHEMOKINE CHEMOKINE, CXCR4, ANATAGONIST, VMIP-II VMI2_KSHV UNP 1 Q98157 24 94 1HFN 1 71 Q98157 A 1 1 71 3 anti-parallel anti-parallel A SER 27 A SER 27 A PRO 30 A PRO 30 A VAL 40 A VAL 40 A LEU 43 A LEU 43 A GLN 49 A GLN 49 A ALA 52 A ALA 52 1 P 1